News | December 29, 2010

Heart Disease, Stroke Deaths Continue to Fall But Costs Remain High

December 29, 2010 - America is winning a battle against heart disease and stroke mortality, but is still losing the war, according to the American Heart Association.

In “Heart Disease and Stroke Statistics – 2011,” published online in Circulation: Journal of the American Heart Association, the association reports that the death rate from heart diseases declined 27.8 percent from 1997 to 2007 (the most recent final data available), and the stroke death rate fell 44.8 percent.

However, during the same period, the total number of inpatient cardiovascular operations and procedures increased 27 percent. The estimated total cost from heart disease and stroke in the United States for 2007 was $286 billion – the highest of any diagnostic group.

"The mortality rate going down is good news; however, the fact that the burden of disease is so high indicates that we may have won a battle against mortality but have not won the war against heart disease and stroke," said Veronique L. Roger, M.D., MPH, lead writer of the report, and professor of medicine and epidemiology at the Mayo Clinic College of Medicine.

Heart disease and stroke remain among the leading killers of Americans, together accounting for one in every three deaths each year.

"We're seeing a decline in deaths for both, particularly for stroke," Roger said. "We can attribute much of that to improved quality of care, with heart and stroke patients getting the care and treatment they need to live longer. But unfortunately the prevalence of these diseases and their risk factors are still high. We need to energize our commitment to strategies that can prevent disease in the first place."

According to the American Heart Association statistics:

• 33.5 percent of adults 20 years and older in America have high blood pressure. Although 80 percent are aware of their condition, less than half have it under control.
• 23.1 percent of men and 18.1 percent of women are cigarette smokers. Additionally, 19.5 percent of students in grades 9 through 12 report current tobacco use.
• 15 percent of adults 20 and older have cholesterol levels of 240 mg/dL or higher.
• 8 percent of adults have been diagnosed with diabetes mellitus; 36.8 percent have prediabetes.
• More than 67 percent of adults are overweight.
• During the past 30 years, the prevalence of obesity in children 6 to 11 years has increased from about 4 percent to more than 20 percent.

The new version of the statistical update is the first to include a chapter detailing how family history and genetics play a role in cardiovascular disease risk.

According to the update, parental history of an early heart attack doubles the risk of a heart attack in men and increases the risk in women by about 70 percent. Sibling history of heart disease doubles the odds of heart disease in both men and women.

For more information: www.heart.org


Related Content

News | Cardiovascular Clinical Studies

Aug. 15, 2024 — According to a new study being presented at ACC Asia 2024 in Delhi, India, drinking over 400 mg of ...

Home August 14, 2024
Home
Videos | Cardiovascular Clinical Studies

As part of DAIC's continuing Thought Leadership Series, this month Editorial Director Melinda Taschetta-Millane sits ...

Home July 30, 2024
Home
News | Cardiovascular Clinical Studies

July 25, 2024 — BioCardia, Inc., a global leader in cellular and cell-derived therapeutics for the treatment of ...

Home July 25, 2024
Home
News | Cardiovascular Clinical Studies

July 18, 2024 — Elucid, a pioneering AI medical technology company providing physicians with imaging analysis software ...

Home July 18, 2024
Home
News | Cardiovascular Clinical Studies

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
News | Cardiovascular Clinical Studies

July 9, 2024 — Microbot Medical Inc. announced the completion of the first procedure in a patient utilizing its LIBERTY ...

Home July 09, 2024
Home
News | Cardiovascular Clinical Studies

June 26, 2024 — Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves ...

Home June 26, 2024
Home
News | Cardiovascular Clinical Studies

June 21, 2024 — Lexicon Pharmaceuticals, Inc. announced that the peer-reviewed Journal of the American College of ...

Home June 21, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — Microbot Medical Inc. announced its agreement with Brigham and Women’s Hospital (BWH), a leading ...

Home June 20, 2024
Home
News | Cardiovascular Clinical Studies

June 20, 2024 — A programming algorithm, being tested by HonorHealth Research Institute for those patients with new or ...

Home June 20, 2024
Home
Subscribe Now